Şunu aradınız:: leverenzymforhøjelse (Danca - İngilizce)

leverenzymforhøjelse var reversibel og ikke forbundet med klinisk manifest leversygdom.
elevations of liver enzymes were reversible and not associated with clinically manifest liver disease.

nøje overvågning er påkrævet af enhver patient, som udvikler leverenzymforhøjelse, med passende dosisjustering eller seponering.
close monitoring is required of any patients who develop liver enzyme elevation with appropriate dose adjustment or discontinuation.

de hyppigste bivirkninger (forekomst ≥10 %) af gilenya 0,5 mg var influenza,sinusitis, hovedpine, diaré, rygsmerter, leverenzymforhøjelse og hoste.
the most frequent adverse reactions (incidence ≥10%) on gilenya 0.5 mg were influenza, sinusitis, headache, diarrhoea, back pain, hepatic enzyme increased and cough.